Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KBH
|
Arthur Reginald Collins
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,028 Added 50.0% |
-
|
Oct 08
2020 |
|
KBH
|
Kevin Paul Eltife
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,028 Added 50.0% |
-
|
Oct 08
2020 |
|
PGNY
|
Tpg Group Holdings (Sbs) Advisors, Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 71,491 Reduced 0.21% |
$1,999,603
$27.97 p/Share
|
Oct 08
2020 |
|
CRVL
|
Corstar Holdings Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 3,664 Reduced 0.06% |
$327,708
$89.44 p/Share
|
Oct 08
2020 |
|
CRVL
|
V Gordon Clemons |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.14% |
$89,050
$89.05 p/Share
|
Oct 08
2020 |
|
MC
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 75.31% |
$760,000
$38.0 p/Share
|
Oct 08
2020 |
|
CVLT
|
Brian Carolan
VP Finance and CFO |
SELL
Open market or private sale
|
Direct | 12,969 Reduced 7.87% |
$554,295
$42.74 p/Share
|
Oct 08
2020 |
|
CVLT
|
Brian Carolan
VP Finance and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 12,969 Added 7.3% |
$347,958
$26.83 p/Share
|
Oct 08
2020 |
|
SPT
|
Justyn Russell Howard
Executive Chair |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 100.0% |
$901,200
$45.06 p/Share
|
Oct 08
2020 |
|
SPT
|
Justyn Russell Howard
Executive Chair |
BUY
Conversion of derivative security
|
Indirect | 20,000 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Glenn R August
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 2,525,000 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Jeffrey Doctoroff
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 301,464 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Dale A. White
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,066,106 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Mark Tabak
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 8,866,592 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Mark Tabak
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,023,609 Added 50.0% |
-
|
Oct 08
2020 |
|
MPLN
|
Allen R Thorpe
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 213,802,446 Added 50.0% |
-
|
Oct 08
2020 |
|
DNLI
|
Carole Ho
Chief Medical Officer |
SELL
Open market or private sale
|
Indirect | 22,906 Reduced 12.09% |
$918,989
$40.12 p/Share
|
Oct 08
2020 |
|
DNLI
|
Carole Ho
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 22,906 Added 10.78% |
$120,944
$5.28 p/Share
|
Oct 08
2020 |
|
AQUA
|
Vincent Grieco
EVP, GC & Secretary |
SELL
Open market or private sale
|
Direct | 13,319 Reduced 21.04% |
$316,326
$23.75 p/Share
|
Oct 08
2020 |
|
AQUA
|
Vincent Grieco
EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 13,319 Added 17.38% |
$61,800
$4.64 p/Share
|
Oct 08
2020 |
|
AQUA
|
Rodney Aulick
Executive Vice President |
SELL
Open market or private sale
|
Direct | 47,011 Reduced 33.35% |
$1,106,169
$23.53 p/Share
|
Oct 08
2020 |
|
AQUA
|
Rodney Aulick
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 47,011 Added 25.01% |
$218,131
$4.64 p/Share
|
Oct 08
2020 |
|
THO
|
Peter Busch Orthwein |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 0.11% |
-
|
Oct 08
2020 |
|
THO
|
Christopher J Klein |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 19.51% |
-
|
Oct 08
2020 |
|
THO
|
Jan Suwinski
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 4.05% |
-
|
Oct 08
2020 |
|
THO
|
J Allen Kosowsky
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 6.3% |
-
|
Oct 08
2020 |
|
THO
|
Wilson R Jones |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 11.07% |
-
|
Oct 08
2020 |
|
THO
|
Amelia Huntington |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 25.7% |
-
|
Oct 08
2020 |
|
THO
|
Andrew E Graves |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 6.29% |
-
|
Oct 08
2020 |
|
THO
|
James L Ziemer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,023 Added 5.32% |
-
|
Oct 08
2020 |
|
THO
|
Kenneth D Julian
SVP OF ADMIN AND HR |
BUY
Grant, award, or other acquisition
|
Direct | 3,881 Added 6.39% |
-
|
Oct 08
2020 |
|
THO
|
W. Todd Woelfer
SVP, CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 7,340 Added 10.68% |
-
|
Oct 08
2020 |
|
THO
|
Robert W Martin
CHIEF EXEC. AND PRES. |
BUY
Grant, award, or other acquisition
|
Direct | 17,979 Added 7.02% |
-
|
Oct 08
2020 |
|
THO
|
Colleen A Zuhl
SR. VP AND CHIEF FIN. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,289 Added 10.1% |
-
|
Oct 08
2020 |
|
RARE
|
Karah Herdman Parschauer
EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 29.16% |
$950,000
$95.0 p/Share
|
Oct 08
2020 |
|
RARE
|
Karah Herdman Parschauer
EVP and Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 22.58% |
$545,000
$54.5 p/Share
|
Oct 08
2020 |
|
W
|
Michael W. Choe
Director |
SELL
Other acquisition or disposition
|
Indirect | 3,490,175 Reduced 100.0% |
-
|
Oct 08
2020 |
|
W
|
Michael W. Choe
Director |
BUY
Other acquisition or disposition
|
Indirect | 8,887 Added 50.0% |
-
|
Oct 08
2020 |
|
W
|
Michael W. Choe
Director |
BUY
Conversion of derivative security
|
Indirect | 3,490,175 Added 50.0% |
$253,037,688
$72.5 p/Share
|
Oct 08
2020 |
|
W
|
Michael W. Choe
Director |
BUY
Other acquisition or disposition
|
Direct | 58,291 Added 38.19% |
-
|
Oct 08
2020 |
|
RUN
|
David Bywater
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 75,558 Reduced 11.94% |
$5,897,302
$78.05 p/Share
|
Oct 08
2020 |
|
RUN
|
David Bywater
Director |
BUY
Grant, award, or other acquisition
|
Direct | 632,731 Added 50.0% |
-
|
Oct 08
2020 |
|
RUN
|
Ellen Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,050 Added 50.0% |
-
|
Oct 08
2020 |
|
MEDP
|
Susan E Burwig
Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 25.26% |
$288,200
$14.41 p/Share
|
Oct 08
2020 |
|
LSCC
|
Mark Jon Nelson
SVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct | 6,872 Reduced 21.14% |
$216,056
$31.44 p/Share
|
Oct 08
2020 |
|
LSCC
|
Mark Jon Nelson
SVP, Sales |
BUY
Exercise of conversion of derivative security
|
Direct | 13,859 Added 29.89% |
-
|
Oct 08
2020 |
|
FND
|
Lisa Laube
PRESIDENT |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 16.18% |
$1,896,000
$79.0 p/Share
|
Oct 08
2020 |
|
FND
|
Lisa Laube
PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 24,000 Added 13.93% |
$86,160
$3.59 p/Share
|
Oct 08
2020 |
|
DLB
|
Steven E Forshay
SVP, Advanced Technology Group |
SELL
Open market or private sale
|
Direct | 834 Reduced 1.34% |
$57,129
$68.5 p/Share
|
Oct 08
2020 |
|
DLB
|
Steven E Forshay
SVP, Advanced Technology Group |
BUY
Exercise of conversion of derivative security
|
Direct | 834 Added 1.32% |
$37,947
$45.5 p/Share
|
Oct 08
2020 |